Mental health is on the decline all over the world. In fact, as reported by Sky News, a report authored by the Lancet-World Psychiatric Association Commission estimates that, “around 5 per cent of the adult population around the world in any year is living with depression. In high-income countries, about half of people suffering from … Continue reading “The Mental Health Crisis is Only Getting Worse”
Tag: NeonMind Biosciences (CSE:NEON)(OTC:NMDBF)
Psychedelics Could Help Treat Mental Health Issues
Psychedelics could be one of the most rewarding opportunities of 2021 and beyond. All as countless studies show how useful they can be in treating mental health issues, such as obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression, and anxiety. Johns Hopkins Medicine launched the Center for Psychedelic and Consciousness Research to study compounds like LSD and … Continue reading “Psychedelics Could Help Treat Mental Health Issues”
Psychedelics to Alter $2.5 Trillion Mental Health Market
Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge in demand for alternative options to traditional mental health support have fueled interest and curiosity in the burgeoning field of psychedelic-assisted therapy. Mounting evidence … Continue reading “Psychedelics to Alter $2.5 Trillion Mental Health Market”